Harbor Capital Advisors Inc. Has $1.39 Million Stock Position in Perrigo Company plc (NYSE:PRGO)

Harbor Capital Advisors Inc. boosted its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 155.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 53,021 shares of the company's stock after purchasing an additional 32,272 shares during the quarter. Harbor Capital Advisors Inc.'s holdings in Perrigo were worth $1,391,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in PRGO. Voisard Asset Management Group Inc. boosted its position in shares of Perrigo by 9.7% in the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company's stock valued at $134,000 after acquiring an additional 450 shares during the period. Creative Planning increased its stake in Perrigo by 3.7% during the third quarter. Creative Planning now owns 18,477 shares of the company's stock valued at $485,000 after acquiring an additional 661 shares during the period. Arizona State Retirement System increased its stake in Perrigo by 1.9% during the second quarter. Arizona State Retirement System now owns 37,939 shares of the company's stock valued at $974,000 after acquiring an additional 699 shares during the period. Swiss National Bank increased its stake in Perrigo by 0.3% during the first quarter. Swiss National Bank now owns 267,600 shares of the company's stock valued at $8,614,000 after acquiring an additional 800 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Perrigo by 3.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,083 shares of the company's stock valued at $747,000 after acquiring an additional 923 shares during the period. Institutional investors own 95.91% of the company's stock.

Perrigo Price Performance

NYSE PRGO traded up $1.99 during trading hours on Wednesday, reaching $27.34. 3,627,494 shares of the company's stock were exchanged, compared to its average volume of 1,624,429. Perrigo Company plc has a one year low of $23.89 and a one year high of $34.60. The firm has a fifty day moving average of $26.26 and a 200-day moving average of $27.53. The company has a quick ratio of 1.24, a current ratio of 1.99 and a debt-to-equity ratio of 0.80.

Perrigo Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th will be issued a dividend of $0.276 per share. This represents a $1.10 annualized dividend and a yield of 4.04%. The ex-dividend date of this dividend is Friday, November 29th. Perrigo's dividend payout ratio is -119.57%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on PRGO shares. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Friday, October 25th. Canaccord Genuity Group reiterated a "buy" rating and issued a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. Piper Sandler lowered their price objective on Perrigo from $36.00 to $35.00 and set an "overweight" rating on the stock in a research note on Thursday, July 11th. Finally, Jefferies Financial Group reiterated a "hold" rating and issued a $30.00 price objective (down from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Perrigo presently has a consensus rating of "Moderate Buy" and an average target price of $37.00.

Insiders Place Their Bets

In other Perrigo news, EVP Ronald Craig Janish sold 13,000 shares of the company's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $29.40, for a total transaction of $382,200.00. Following the transaction, the executive vice president now owns 20,553 shares of the company's stock, valued at approximately $604,258.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Ronald Craig Janish sold 13,000 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $29.40, for a total value of $382,200.00. Following the transaction, the executive vice president now owns 20,553 shares of the company's stock, valued at $604,258.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Svend Andersen sold 28,300 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $27.75, for a total value of $785,325.00. Following the completion of the transaction, the executive vice president now directly owns 73,553 shares in the company, valued at approximately $2,041,095.75. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 50,254 shares of company stock valued at $1,411,969. 0.40% of the stock is currently owned by corporate insiders.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.